Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Roche spends $2.7B to acquire new drugs for obesity, diabetes | 19 important topics for AFib experts to study

News You Need to Know Today
Roche spends $2.7B to acquire new drugs for obesity, diabetes | 19 important topics for AFib experts to study
Tuesday, December 5, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Roche spends $2.7B to acquire biotech company with multiple obesity, diabetes drugs in development

Roche, one of the world’s largest pharmaceutical companies, will gain both oral and injectable assets as a result of this acquisition.

READ MORE >
healthcare money economics dollar stethoscope acquire merger
Share on Twitter Share on Facebook Share on Linkedin

Roche spends $2.7B to acquire biotech company with multiple obesity, diabetes drugs in development

Share on Twitter Share on Facebook Share on Linkedin
healthcare money economics dollar stethoscope acquire merger
Roche, one of the world’s largest pharmaceutical companies, will gain both oral and injectable assets as a result of this acquisition.
READ MORE >

Learning more about AFib: 19 important topics for cardiologists, other heart specialists to investigate

New AFib recommendations from the American College of Cardiology and American Heart Association covered significant ground—but there is still much more to learn, experts explained. 

READ MORE >
older patient with a doctor at their house
Share on Twitter Share on Facebook Share on Linkedin

Learning more about AFib: 19 important topics for cardiologists, other heart specialists to investigate

Share on Twitter Share on Facebook Share on Linkedin
older patient with a doctor at their house
New AFib recommendations from the American College of Cardiology and American Heart Association covered significant ground—but there is still much more to learn, experts explained. 
READ MORE >

Featured Articles

New AFib guidelines include higher recommendations for catheter ablation, LAAO

Cardiologists, electrophysiologists, surgeons and patient representatives all worked together on the updated guidelines, which were published in both the Journal of the American College of Cardiology and Circulation.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

New AFib guidelines include higher recommendations for catheter ablation, LAAO

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Cardiologists, electrophysiologists, surgeons and patient representatives all worked together on the updated guidelines, which were published in both the Journal of the American College of Cardiology and Circulation.
READ MORE >

FDA approves early feasibility study for total artificial heart technology

The device is intended to be a bridge for heart failure patients waiting to receive a full heart transplant.

READ MORE >
BiVACOR Total Artificial Heart. BiVACOR, an international medical device company with headquarters in the United States and Australia, has received approval from the U.S. Food and Drug Administration (FDA) to kick off an early feasibility study (EFS) for its total artificial heart (TAH) technology.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves early feasibility study for total artificial heart technology

Share on Twitter Share on Facebook Share on Linkedin
BiVACOR Total Artificial Heart. BiVACOR, an international medical device company with headquarters in the United States and Australia, has received approval from the U.S. Food and Drug Administration (FDA) to kick off an early feasibility study (EFS) for its total artificial heart (TAH) technology.
The device is intended to be a bridge for heart failure patients waiting to receive a full heart transplant.
READ MORE >

In Case You Missed It

The expanding scope of FDG-PET in nuclear cardiac imaging

Jamie Bourque, MD, spoke to Cardiovascular Business about the growing number of ways FDG-PET scans are being used in cardiology. This includes evaluating inflammation, tracking EP device infections and much more. 

READ MORE >
Jamie Bourque, MD, discusses fluorodeoxyglucose (FDG) and its growing use cases in cardiac PET imaging He discussed the radiotracer in sessions at ASNC 2023. #ASNC #ASNC23 #ASNC2023
Share on Twitter Share on Facebook Share on Linkedin

The expanding scope of FDG-PET in nuclear cardiac imaging

Share on Twitter Share on Facebook Share on Linkedin
Jamie Bourque, MD, discusses fluorodeoxyglucose (FDG) and its growing use cases in cardiac PET imaging He discussed the radiotracer in sessions at ASNC 2023. #ASNC #ASNC23 #ASNC2023
Jamie Bourque, MD, spoke to Cardiovascular Business about the growing number of ways FDG-PET scans are being used in cardiology. This includes evaluating inflammation, tracking EP device infections and much more. 
READ MORE >

Cardiologists may want to rethink how they track prosthesis-patient mismatch after TAVR

Researchers evaluated two techniques for predicting PPM after TAVR, comparing them to how cardiologists typically check for PPM in day-to-day practice. 

READ MORE >
The Bern TAVI Registry looked at 2,500 TAVR patients to determine the level of prosthesis-patient mismatch (PPM) using transthoracic echocardiography (TTE), predicting PPM based one the size of the valve used, or using CT measurements of the aortic annulus to see which was method was most accurate at predicting PPM. Image courtesy of Tomii et al. 
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists may want to rethink how they track prosthesis-patient mismatch after TAVR

Share on Twitter Share on Facebook Share on Linkedin
The Bern TAVI Registry looked at 2,500 TAVR patients to determine the level of prosthesis-patient mismatch (PPM) using transthoracic echocardiography (TTE), predicting PPM based one the size of the valve used, or using CT measurements of the aortic annulus to see which was method was most accurate at predicting PPM. Image courtesy of Tomii et al. 
Researchers evaluated two techniques for predicting PPM after TAVR, comparing them to how cardiologists typically check for PPM in day-to-day practice. 
READ MORE >

In Other News

Jury convicts radiology business owner in imaging-contrast kickback scheme

Neurosurgeon Payam Toobian, MD, oversaw a scam in which two physicians would receive gift cards and cash in exchange for referrals to his imaging center.

READ MORE >
jury court verdict juror lawsuit trial
Share on Twitter Share on Facebook Share on Linkedin

Jury convicts radiology business owner in imaging-contrast kickback scheme

Share on Twitter Share on Facebook Share on Linkedin
jury court verdict juror lawsuit trial
Neurosurgeon Payam Toobian, MD, oversaw a scam in which two physicians would receive gift cards and cash in exchange for referrals to his imaging center.
READ MORE >

RSNA 2023: Hospital imaging systems may be gateways for ransomware, expert warns

Cybersecurity consultant Richard Staynings argued legacy medical devices are inherently insecure—and likely to remain in hospitals for decades to come.

READ MORE >
money cybersecurity ransomware health IT data breach hacker
Share on Twitter Share on Facebook Share on Linkedin

RSNA 2023: Hospital imaging systems may be gateways for ransomware, expert warns

Share on Twitter Share on Facebook Share on Linkedin
money cybersecurity ransomware health IT data breach hacker
Cybersecurity consultant Richard Staynings argued legacy medical devices are inherently insecure—and likely to remain in hospitals for decades to come.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New SCAI president outlines focus into 2027 | DCBs have similar outcomes to DES | GLP-1s lower AFib
‘Father of modern cardiology’ dies at 96 | High-risk women missing out on care | Tirzepatide beneficial for TAVR & PCI patients
Week in Review: Cardiologist pay climbs 10% | Energy drinks & heart disease | CMS, FDA propose major change | Treating HFmrEF
Strokes after PFA | Hospital sues practice | FDA approves fast-acting drug for children | The cardiologist shortage continues
CMS & FDA propose major Medicare changes | Big news for Biotronik | New imaging data on MINOCA | The first procedure of its kind
News Alert: Trump administration moves to speed up Medicare coverage for breakthrough devices
Experts agree: HFmrEF should not be ignored | Cardiologist makes 'Magic' with new device | When bioprosthetic mitral valves fail

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …9
    • Page 10
    • Page 11
    • Page 12
    • Current page 13
    • Page 14
    • Page 15
    • Page 16
    • Page 17 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup